Treatment of Vulvar Lichen Sclerosus in Extragenital Lichen Sclerosus

When vulvar lichen sclerosus occurs as part of an extragenital presentation — with lichen sclerosus affecting skin beyond the genital region — the clinical situation calls for an approach that accounts for the full extent of disease. This setting is recognised as a distinct scenario with its own evidence base.

Clinical Scenario

Extragenital lichen sclerosus: involvement of skin at sites outside the genital area. The evidence specifically addressing treatment in this extragenital context is more limited than for isolated vulvar disease, and treatment selection reflects this.

Treatment Approach

Management involves topical therapy applied directly to the affected skin — the full protocol specifies which agents are used and the conditions under which they are applied.

Instant Access to Structured Evidence-Based Regimens

References

There are fewer studies for the treatment of extragenital LS.
UVA1 phototherapy is a potential first-line treatment option.
Potent topical steroids and topical calcipotriol, possibly under occlusion, may be tried in extragenital LS.

DOI: 10.1111/jdv.18102

View source ↗